155 related articles for article (PubMed ID: 2308986)
21. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
22. A protocol for the enrichment of different types of CFU-S from fetal mouse liver.
Corso A; Hogeweg-Platenburg MG; De Vries P; Visser JW
Haematologica; 1993; 78(1):5-11. PubMed ID: 8098311
[TBL] [Abstract][Full Text] [Related]
23. Enrichment of progenitor cells from human marrow.
Baines P; Masters G; Booth M; Jacobs A
Exp Hematol; 1987 Aug; 15(7):809-13. PubMed ID: 3609184
[TBL] [Abstract][Full Text] [Related]
24. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
25. Isolation, characterization and functional activity of human marrow stromal progenitors in hemopoiesis.
Simmons PJ; Gronthos S; Zannettino A; Ohta S; Graves S
Prog Clin Biol Res; 1994; 389():271-80. PubMed ID: 7700911
[TBL] [Abstract][Full Text] [Related]
26. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.
Ball ED; Keefe KA; McDermott JM
Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116
[TBL] [Abstract][Full Text] [Related]
27. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.
Mangan KF; D'Alessandro L; Mullaney MT
J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910
[TBL] [Abstract][Full Text] [Related]
28. Human leukocyte function-associated antigens on lympho-hemopoietic precursor cells.
Campana D; Sheridan B; Tidman N; Hoffbrand AV; Janossy G
Eur J Immunol; 1986 May; 16(5):537-42. PubMed ID: 3516710
[TBL] [Abstract][Full Text] [Related]
29. Purging of T-lymphocytes with magnetic affinity colloid.
Yau JC; Reading CL; Thomas MW; Davaraj BM; Tindle SE; Jagannath S; Dicke KA
Exp Hematol; 1990 Mar; 18(3):219-22. PubMed ID: 2303117
[TBL] [Abstract][Full Text] [Related]
30. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
[TBL] [Abstract][Full Text] [Related]
31. Immunological separation of two CFU-GM subsets showing different responsiveness to T-cell derived growth factors.
Tarella C; Ferrero D; Caracciolo D; Badoni R; Bellone G; Gallo E
J Clin Lab Immunol; 1988 Apr; 25(4):185-90. PubMed ID: 3262763
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
33. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
[TBL] [Abstract][Full Text] [Related]
34. Isolation of hemopoietic stem cell subsets from murine bone marrow: II. Evidence for an early precursor of day-12 CFU-S and cells associated with radioprotective ability.
Ploemacher RE; Brons NH
Exp Hematol; 1988 Jan; 16(1):27-32. PubMed ID: 2891557
[TBL] [Abstract][Full Text] [Related]
35. T lymphocyte depletion of human peripheral blood and bone marrow using monoclonal antibodies and magnetic microspheres.
Gee AP; Lee C; Sleasman JW; Madden M; Ugelstad J; Barrett DJ
Bone Marrow Transplant; 1987 Aug; 2(2):155-63. PubMed ID: 2901878
[TBL] [Abstract][Full Text] [Related]
36. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268
[TBL] [Abstract][Full Text] [Related]
37. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.
Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A
Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468
[TBL] [Abstract][Full Text] [Related]
38. Isolation of C15: a novel antibody generated by phage display against mesenchymal stem cell-enriched fractions of adult human marrow.
Letchford J; Cardwell AM; Stewart K; Coogans KK; Cox JP; Lee M; Beresford JN; Perry MJ; Welham MJ
J Immunol Methods; 2006 Jan; 308(1-2):124-37. PubMed ID: 16386756
[TBL] [Abstract][Full Text] [Related]
39. Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation.
Chang Q; Harvey K; Akard L; Thompson J; Dugan MJ; English D; Jansen J
Exp Hematol; 1997 May; 25(5):423-31. PubMed ID: 9168064
[TBL] [Abstract][Full Text] [Related]
40. A monoclonal antibody specific for immature human hemopoietic cells and T lineage cells.
Bodger MP; Francis GE; Delia D; Granger SM; Janossy G
J Immunol; 1981 Dec; 127(6):2269-74. PubMed ID: 6975315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
